Company Filing History:
Years Active: 2000
Title: The Innovative Mind of Christensen Thorkild
Introduction: Christensen Thorkild, an accomplished inventor based in Allerødk, Denmark, has made significant contributions to the field of pharmaceuticals, particularly in the formulation of human growth hormones. His innovative approach has led to the development of a highly stable pharmaceutical formulation, enhancing the storage and transport of essential medications.
Latest Patents: Thorkild holds a patent for a groundbreaking pharmaceutical formulation of human growth hormone pretreated with zinc. This formulation effectively combines growth hormone with zinc, and optionally includes lysine or calcium ions, to achieve remarkable stability against deamidation, oxidation, and cleavage of peptide bonds. This stability ensures that the product can be stored and shipped in either a lyophilized state or in a dissolved/re-dissolved form at ambient temperature, which is crucial for maintaining its efficacy.
Career Highlights: Throughout his career, Thorkild has been associated with Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care and hormone replacement therapies. His work has directly impacted the pharmaceutical landscape, providing new solutions for the effective delivery and stability of important hormonal treatments.
Collaborations: In his journey of innovation, Thorkild has collaborated with notable coworkers such as Hans Holmegaard Sørensen and Ole Hvilsted Olsen. These partnerships have fostered an environment of creativity and shared knowledge, contributing to the successful development of their pharmaceutical products.
Conclusion: Christensen Thorkild is a prominent figure in the realm of pharmaceutical innovations, particularly regarding human growth hormones. His patented formulation exemplifies his commitment to enhancing the safety and efficacy of therapeutic treatments. As a key member of Novo Nordisk A/S, Thorkild continues to push the boundaries of what's possible in the pharmaceutical sector, illustrating the profound impact that dedicated inventors have on healthcare and humanity.